Illegal ayurvedic medicine factory busted in Valsad, raw materials, machinery seized

Valsad:  A factory manufacturing Ayurvedic medicines illegally has been busted behind the Vishwambhari temple in Rabda, Valsad district of Gujarat. Food and Drug Administration (FDA) officials have raided the factory and taken massive action.

During the raid, the FDA has found a large quantity of various types of Ayurvedic medicines, such as powder, pills, tablets, extracts, soaps and oils. In addition, raw materials and machinery used to make the medicine have also been seized.
Preliminary investigation has revealed that this factory was running without any proper permission. This factory was manufacturing medicines illegally in violation of the guidelines of the Food and Drug Department.

Samples of the seized medicines have been sent to the laboratory so that their quality and safety can be assessed. Further legal action will be taken after receiving the laboratory report.

This incident has raised concerns about illegal Ayurvedic medicine manufacturing in Gujarat. FDA is continuously monitoring such illegal activities and strict action will be taken.

Related Posts

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

New Delhi: In a major crackdown on the sale of expired and substandard products, the Central Range team of Delhi Police Crime Branch has arrested one person and seized nearly…

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

Washington:  On March 18, 2026, the U.S. Food and Drug Administration (FDA) issued a draft guidance titled General Considerations for the Use of New Approach Methodologies in Drug Development. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

US market to dent India pharma earnings even as domestic growth remains firm

US market to dent India pharma earnings even as domestic growth remains firm

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg